Published in J Clin Psychopharmacol on June 01, 2001
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling | NCT00326807
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction (2012) 2.64
Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94
Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berl) (2004) 1.69
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) (2004) 1.66
Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. J Clin Psychiatry (2015) 1.62
Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend (2004) 1.28
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15
A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men. J Consult Clin Psychol (2012) 1.13
Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats. Psychopharmacology (Berl) (2009) 1.13
New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials. Biol Psychiatry (2007) 1.12
Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcohol Clin Exp Res (2009) 1.12
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res (2009) 1.06
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS Neurol Disord Drug Targets (2010) 1.06
Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology (2011) 1.05
Targeted naltrexone for problem drinkers. J Clin Psychopharmacol (2009) 1.04
Medical treatment of alcohol dependence: a systematic review. Int J Psychiatry Med (2011) 1.03
Establishing the feasibility of measuring performance in use of addiction pharmacotherapy. J Subst Abuse Treat (2013) 1.00
Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol (2012) 0.97
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl) (2014) 0.95
Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response. Addict Behav (2013) 0.94
The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Front Psychiatry (2010) 0.93
Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking. Alcohol Clin Exp Res (2013) 0.91
Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull (2006) 0.87
A pilot study of naltrexone and BASICS for heavy drinking young adults. Addict Behav (2008) 0.87
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy (2008) 0.85
Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats. Psychopharmacology (Berl) (2014) 0.85
Methodology of a randomized double-blind clinical trial for comorbid posttraumatic stress disorder and alcohol dependence. Ment Health Subst Use (2010) 0.84
Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment. Alcohol (2008) 0.83
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol (2016) 0.80
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav (2012) 0.78
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs (2015) 0.77
Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment. Psychopharmacology (Berl) (2007) 0.77
Targeted opioid receptor antagonists in the treatment of alcohol use disorders. CNS Drugs (2013) 0.76
Patient-centered care interventions for the management of alcohol use disorders: a systematic review of randomized controlled trials. Patient Prefer Adherence (2016) 0.75
Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy. Indian J Psychiatry (2007) 0.75
Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care. J Addict Med (2016) 0.75
Kappa-opioid receptors differentially regulate low and high levels of ethanol intake in female mice. Brain Behav (2016) 0.75
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology (2017) 0.75
Genetic influences on brain structure. Nat Neurosci (2001) 8.39
Attempted suicide in Europe: rates, trends and sociodemographic characteristics of suicide attempters during the period 1989-1992. Results of the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatr Scand (1996) 3.25
Suicides after pregnancy in Finland, 1987-94: register linkage study. BMJ (1996) 2.79
Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry (1999) 2.44
The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry (1998) 2.39
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet (1999) 2.15
Cancer and suicide. Ann Oncol (1991) 2.02
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med (1986) 1.91
Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke (2000) 1.84
Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: a double-blind placebo-controlled randomized trial. J Clin Psychopharmacol (2003) 1.82
Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet (2000) 1.77
Inadequate dosaging in general practice of tricyclic vs. other antidepressants for depression. Acta Psychiatr Scand (1998) 1.75
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
Long-term risk factors for suicide mortality after attempted suicide--findings of a 14-year follow-up study. Acta Psychiatr Scand (2001) 1.59
A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol (1997) 1.58
Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet (2001) 1.57
Development of an alcohol-deprivation effect in rats. Q J Stud Alcohol (1968) 1.52
Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry (1998) 1.50
Outcome of attempted suicide and psychiatric consultation: risk factors and suicide mortality during a five-year follow-up. Acta Psychiatr Scand (1991) 1.50
Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry (2004) 1.49
Mental disorders and comorbidity in attempted suicide. Acta Psychiatr Scand (1996) 1.49
Seasonal variation in bipolar disorder. Br J Psychiatry (1996) 1.47
The feasibility of effective psychopharmacological treatments for alcoholism. Br J Addict (1987) 1.47
DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.47
A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol Psychiatry (2005) 1.44
Disability pensions in severely disturbed in-patient adolescents. Twenty-year prospective study. Br J Psychiatry (1998) 1.44
Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Soc Psychiatry Psychiatr Epidemiol (2000) 1.41
Seasonal affective disorder. Lancet (1998) 1.39
Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol (1996) 1.32
Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest (1992) 1.30
Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res (1998) 1.30
Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett (1997) 1.29
Major depressive episode among young adults: CIDI-SF versus SCAN consensus diagnoses. Psychol Med (2002) 1.28
Proton MRS in twin pairs discordant for schizophrenia. Mol Psychiatry (2008) 1.27
Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry (2007) 1.24
Schizophrenia in the genetic isolate of Finland. Am J Med Genet (1997) 1.22
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree. Genome Res (1995) 1.22
Maintenance and manipulation in spatial working memory: dissociations in the prefrontal cortex. Neuroimage (2002) 1.21
Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol Clin Exp Res (2001) 1.21
Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc Natl Acad Sci U S A (1988) 1.21
Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ (1994) 1.18
Cause-specific mortality by marital status and social class in Finland during 1969--1971. Soc Sci Med Med Psychol Med Sociol (1979) 1.18
Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry (1999) 1.18
Respiratory effects of sectioning the carotid sinus glossopharyngeal and abdominal vagal nerves in the awake rat. J Physiol (1985) 1.17
Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res (1995) 1.17
Excess mortality of suicide attempters. Soc Psychiatry Psychiatr Epidemiol (2001) 1.15
New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett (1997) 1.14
Mental disorders in young adulthood. Psychol Med (2008) 1.13
Restoration of hypoxic respiratory responses in the awake rat after carotid body denervation by sinus nerve section. J Physiol (1986) 1.12
Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science (1985) 1.10
Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol Psychiatry (1998) 1.08
A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J (2004) 1.08
Recent life events, social support and suicide. Acta Psychiatr Scand Suppl (1994) 1.07
Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res (1998) 1.06
Initial acceptance of ethanol: gustatory factors and patterns of alcohol drinking. Alcohol (1990) 1.04
One-month prevalence of depression and other DSM-IV disorders among young adults. Psychol Med (2001) 1.04
Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13. Am J Hum Genet (1998) 1.04
Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul Pept (1990) 1.03
Localization by kainic acid lesions of neurones transmitting the carotid chemoreceptor stimulus for respiration in rat. J Physiol (1988) 1.03
Attempted suicide rates and trends during a period of severe economic recession in Helsinki, 1989-1997. Soc Psychiatry Psychiatr Epidemiol (2001) 1.03
Plasma cortisol, androstenedione, testosterone and luteinizing hormone in running exercise of different intensities. Scand J Clin Lab Invest (1980) 1.03
Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol (1999) 1.02
Suicide and the use of antidepressants. Drug treatment of depression is inadequate. BMJ (1994) 1.02
Psychotropic drugs and impairment of psychomotor functions. Psychopharmacologia (1975) 1.02
Brain ethanol levels after voluntary ethanol drinking in AA and Wistar rats. Alcohol (1999) 1.02
Accuracy of register-based schizophrenia diagnoses in a genetic study. Eur Psychiatry (1998) 1.01
Bright light improves vitality and alleviates distress in healthy people. J Affect Disord (2000) 1.01
Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol Psychiatry (2009) 1.01
Suicide mortality among medical doctors in Finland: are females more prone to suicide than their male colleagues? Psychol Med (1997) 1.01
Brief intervention for male heavy drinkers in routine general practice: a three-year randomized controlled study. Alcohol Alcohol (2001) 1.00
Body composition in psychotic disorders: a general population survey. Psychol Med (2008) 1.00
Health care contacts before and after attempted suicide among adolescent and young adult versus older suicide attempters. Psychol Med (2004) 0.99
Suicide attempts in which alcohol is involved: a special group in general hospital emergency rooms. Acta Psychiatr Scand (1995) 0.99
Mental disorders in young and middle aged men who commit suicide. BMJ (1995) 0.99
Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry (1999) 0.99
Regulation of nerve growth factor biosynthesis by beta-adrenergic receptor activation in astrocytoma cells: a potential role of c-Fos protein. Proc Natl Acad Sci U S A (1989) 0.99
Factors associated with early dropout from adolescent psychiatric outpatient treatment. J Am Acad Child Adolesc Psychiatry (2000) 0.98
Social factors and the gender difference in mortality. Soc Sci Med (1986) 0.98
Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am J Psychiatry (2000) 0.97
Behavioral and physiological changes associated with various durations of alcohol deprivation in rats. Q J Stud Alcohol (1973) 0.97
Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. J Affect Disord (2008) 0.97
Life events and other risk factors for somatic symptoms in adolescence. Pediatrics (1995) 0.97
Brain stem projections of the glossopharyngeal nerve and its carotid sinus branch in the rat. Neuroscience (1987) 0.96
Differentiation of PC12 pheochromocytoma cells by sodium butyrate. Brain Res (1987) 0.96
Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats. Life Sci (2000) 0.96
Regional variation in the incidence of schizophrenia in Finland: a study of birth cohorts born from 1950 to 1969. Psychol Med (2001) 0.96
The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice. Biochem Mol Biol Int (1998) 0.96
Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ. J Pharmacol Exp Ther (1986) 0.95
Hopelessness, impulsiveness and intent among suicide attempters with major depression, alcohol dependence, or both. Acta Psychiatr Scand (1997) 0.95
Human cardiorespiratory responses to acute cold exposure. Clin Exp Pharmacol Physiol (1975) 0.95
The AA and ANA rat lines, selected for differences in voluntary alcohol consumption. Experientia (1989) 0.94
Brain ethanol in AA, ANA, and Wistar rats monitored with one-minute microdialysis. Alcohol (1994) 0.93
Serum sialic acid in a random sample of the general population. Clin Chem (1999) 0.93
The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med (1996) 0.93
The alcohol-deprivation effect. Influence of various factors. Q J Stud Alcohol (1972) 0.93